Back to
Point72 Asset Management, L.P.
KNSA
Showing 0 of 9 quarters
Position history for
Point72 Asset Management, L.P.'s holdings in Kiniksa Pharmaceuticals International, plc
No. Point72 Asset Management exited its KNSA (Kiniksa Pharmaceuticals International) position in Q2 2022. Its Q1 2022 13F listed 329,798 shares worth $3.3M. Point72 Asset Management first reported KNSA in Q2 2019 and held it in 6 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.